The modified light chain of inter-alpha inhibitor/antibody fusion protein, MR1007, improves survival in the rabbit sepsis models

per Nakamura, Masaki, Takeuchi, Takashi, Yatagai, Yukiko, Naito, Katsuki, Shirakawa, Kamon, Hosaka, Yoshitaka, Furusako, Shoji
Publicat 2007

In vivo Antitumor Mechanism of Natural Human Tumor Necrosis Factor Involving a T Cell‐mediated Immunological Route

per Asami, Tetsuya, Imai, Meroni, Tanaka, Yasuo, Hosaka, Yoshitaka, Kato, Kazuharu, Nakamura, Norio, Horisawa, Yoshifumi, Ashida, Yoshikazu, Kanamori, Toshinori, Nobuhara, Masahiro, Kurimoto, Masashi
Publicat a Jpn J Cancer Res (1989)

A novel free fatty acid receptor 1 (GPR40/FFAR1) agonist, MR1704, enhances glucose‐dependent insulin secretion and improves glucose homeostasis in rats

per Tsuda, Naoto, Kawaji, Atsuko, Sato, Toshihiro, Takagi, Mitsuhiro, Higashi, Chika, Kato, Yutaka, Ogawa, Kumiko, Naba, Hiroyasu, Ohkouchi, Munetaka, Nakamura, Masaki, Hosaka, Yoshitaka, Sakaki, Junichi
Publicat a Pharmacol Res Perspect (2017)

A novel antiplatelet antibody therapy that induces cAMP-dependent endocytosis of the GPVI/Fc receptor γ-chain complex

per Takayama, Hiroshi, Hosaka, Yoshitaka, Nakayama, Kazuyuki, Shirakawa, Kamon, Naitoh, Katsuki, Matsusue, Tomokazu, Shinozaki, Mikihiko, Honda, Motoyasu, Yatagai, Yukiko, Kawahara, Tetsushi, Hirose, Jiro, Yokoyama, Tooru, Kurihara, Michiru, Furusako, Shoji
Publicat 2008